Associations of Sleep Deficiency With Sexual Risk Behaviors and HIV Treatment Outcomes Among Men Who Have Sex With Men Living With or at High Risk of Acquiring HIV.

IF 2.9 3区 医学 Q3 IMMUNOLOGY
Allison D Rosen, Marjan Javanbakht, Steven J Shoptaw, Marissa J Seamans, Pamina M Gorbach
{"title":"Associations of Sleep Deficiency With Sexual Risk Behaviors and HIV Treatment Outcomes Among Men Who Have Sex With Men Living With or at High Risk of Acquiring HIV.","authors":"Allison D Rosen, Marjan Javanbakht, Steven J Shoptaw, Marissa J Seamans, Pamina M Gorbach","doi":"10.1097/QAI.0000000000003444","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Associations of sleep deficiency and methamphetamine use with sexual health and HIV treatment outcomes are poorly understood.</p><p><strong>Setting: </strong>A longitudinal cohort of men who have sex with men at risk for or living with HIV (the mSTUDY) was analyzed. This analysis included 1445 study visits among 382 participants. Data were collected from June 2018 to February 2022.</p><p><strong>Methods: </strong>Semiannual study visits included self-interviews for sleep deficiency, sexual behaviors, substance use, and HIV treatment. Sleep deficiency was measured using the Pittsburgh Sleep Quality Index. Participants provided specimens for HIV viral load and sexually transmitted infection (STI) testing (chlamydia, gonorrhea, syphilis). Associations between sleep deficiency and STI/HIV outcomes were estimated using multiple logistic regression.</p><p><strong>Results: </strong>Across visits, the prevalence of sleep deficiency was 56%, with 33% reporting methamphetamine use and 55% living with HIV. Sleep deficiency was associated with reporting at least 1 new anal sex partner (aOR = 1.62, 95% CI: 1.21 to 2.15), exchange sex (aOR = 2.71, 95% CI: 1.15 to 6.39), sex party attendance (aOR = 2.60, 95% CI: 1.68 to 4.04), and missing HIV medications (aOR = 1.91, 95% CI: 1.16 to 3.14). The association between sleep deficiency and exchange sex differed for participants who did and did not report the use of methamphetamine (P = 0.09).</p><p><strong>Conclusion: </strong>Sleep deficiency was associated with sexual health and HIV treatment behaviors after accounting for methamphetamine use. Sleep health should be considered in STI/HIV prevention, particularly for those who use methamphetamine.</p>","PeriodicalId":14588,"journal":{"name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","volume":"96 4","pages":"326-333"},"PeriodicalIF":2.9000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11207189/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAIDS Journal of Acquired Immune Deficiency Syndromes","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/QAI.0000000000003444","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Associations of sleep deficiency and methamphetamine use with sexual health and HIV treatment outcomes are poorly understood.

Setting: A longitudinal cohort of men who have sex with men at risk for or living with HIV (the mSTUDY) was analyzed. This analysis included 1445 study visits among 382 participants. Data were collected from June 2018 to February 2022.

Methods: Semiannual study visits included self-interviews for sleep deficiency, sexual behaviors, substance use, and HIV treatment. Sleep deficiency was measured using the Pittsburgh Sleep Quality Index. Participants provided specimens for HIV viral load and sexually transmitted infection (STI) testing (chlamydia, gonorrhea, syphilis). Associations between sleep deficiency and STI/HIV outcomes were estimated using multiple logistic regression.

Results: Across visits, the prevalence of sleep deficiency was 56%, with 33% reporting methamphetamine use and 55% living with HIV. Sleep deficiency was associated with reporting at least 1 new anal sex partner (aOR = 1.62, 95% CI: 1.21 to 2.15), exchange sex (aOR = 2.71, 95% CI: 1.15 to 6.39), sex party attendance (aOR = 2.60, 95% CI: 1.68 to 4.04), and missing HIV medications (aOR = 1.91, 95% CI: 1.16 to 3.14). The association between sleep deficiency and exchange sex differed for participants who did and did not report the use of methamphetamine (P = 0.09).

Conclusion: Sleep deficiency was associated with sexual health and HIV treatment behaviors after accounting for methamphetamine use. Sleep health should be considered in STI/HIV prevention, particularly for those who use methamphetamine.

在感染艾滋病病毒或有感染艾滋病病毒高风险的男男性行为者中,睡眠不足与性风险行为和艾滋病病毒治疗结果的关系。
背景:睡眠不足和吸食甲基苯丙胺与性健康和艾滋病治疗结果之间的关系尚不清楚:人们对睡眠不足和使用甲基苯丙胺与性健康和艾滋病治疗结果之间的关系知之甚少:分析了一个纵向队列(mSTUDY),该队列的对象是有感染 HIV 风险或已感染 HIV 的男男性行为者。该分析包括 382 名参与者的 1445 次研究访问。数据收集时间为 2018 年 6 月至 2022 年 2 月:每半年一次的研究访问包括睡眠不足、性行为、药物使用和艾滋病治疗的自我访谈。睡眠不足采用匹兹堡睡眠质量指数进行测量。参与者提供标本进行 HIV 病毒载量和性传播感染 (STI) 检测(衣原体、淋病、梅毒)。采用多元逻辑回归法估算了睡眠不足与 STI/HIV 结果之间的关系:在所有访问中,睡眠不足的发生率为 56%,33% 的人报告使用过甲基苯丙胺,55% 的人感染了艾滋病毒。睡眠不足与报告至少有一个新肛交伴侣(aOR = 1.62,95% CI:1.21 至 2.15)、性交换(aOR = 2.71,95% CI:1.15 至 6.39)、参加性派对(aOR = 2.60,95% CI:1.68 至 4.04)和缺少 HIV 药物(aOR = 1.91,95% CI:1.16 至 3.14)有关。对于报告和未报告使用甲基苯丙胺的参与者,睡眠不足与性交换之间的关系有所不同(P = 0.09):结论:在考虑使用甲基苯丙胺的情况后,睡眠不足与性健康和艾滋病治疗行为有关。在性传播感染/艾滋病预防中应考虑睡眠健康,尤其是对于使用甲基苯丙胺的人群。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.80
自引率
5.60%
发文量
490
审稿时长
3-6 weeks
期刊介绍: JAIDS: Journal of Acquired Immune Deficiency Syndromes​ seeks to end the HIV epidemic by presenting important new science across all disciplines that advance our understanding of the biology, treatment and prevention of HIV infection worldwide. JAIDS: Journal of Acquired Immune Deficiency Syndromes is the trusted, interdisciplinary resource for HIV- and AIDS-related information with a strong focus on basic and translational science, clinical science, and epidemiology and prevention. Co-edited by the foremost leaders in clinical virology, molecular biology, and epidemiology, JAIDS publishes vital information on the advances in diagnosis and treatment of HIV infections, as well as the latest research in the development of therapeutics and vaccine approaches. This ground-breaking journal brings together rigorously peer-reviewed articles, reviews of current research, results of clinical trials, and epidemiologic reports from around the world.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信